SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.92+0.2%Feb 4 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (11192)8/16/1999 2:49:00 PM
From: aknahow  Read Replies (2) of 17367
 
Chord with me.

Ever wonder why...

Why so few institutions own XOMA?
Why so little stock owned by insiders?
Why no major pharmaceutical partners?
Why the move to Bermuda?
Why they only can slice and dice?
Why they took only mild cases into the P III Trial? (Use 1-8 instead of 8-15).
Why meningococcemia trial was extended?
Why so few deaths occurred?
Why they chose such a small market as meningococcemia?
Why their trial design must have been flawed?
Why they are only involved in three P III trials?
Why volume is sow low?
Why volume is slow high?
Why Murphy likes XOMA?

O.K. Bluegreen. These were sincere questions. Don't chord with me then.

I bet you don't even care two cents about these questions.

Neither do I. <VBG>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext